As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

The research team, led by Professor Tobin Filleter, has engineered nanomaterials that offer unprecedented strength, weight, and customizability. These materials are composed of tiny building blocks, ...

Biomedical engineers have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing proteins. Inspired by ...

Every cell in your body contains the same genetic sequence, yet each cell expresses only a subset of those genes. These ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing ...

Regional Analysis: North America holds 40% of the Generative AI Life Sciences market... Lawrence John Prudour +91 91308 55334 ...

will lead the newly established CoreAI – Platform and Tools group. The CoreAI group is tasked with building an end-to-end AI stack to support both Microsoft’s internal needs and its third ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

The Malaga 6G Research and Innovation lab is an integral part of Keysight’s European infrastructure. Keysight Laboratories engages with customers, markets, universities, and research communities along ...

By altering the metabolism of the skin, the Zika virus guarantees its own survival, resulting in turning humans into mosquito ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...